By Maggie Fick, Mrinalika Roy and Sabrina ValleSAN FRANCISCO, Jan 12 (Reuters) - Oral weight-loss drugs could account for a ...

Novo Nordisk CEO Mike Doustdar said on Monday as many as 1.5 million patients in the U.S. may be using compounded versions of ...

The general mood among these heavyweight investors is divided, with 35% leaning bullish and 37% bearish. Among these notable options, 12 are puts, totaling $1,065,123, and 33 are calls, amounting to ...

Wegovy pill introduction in the U.S. may serve as the turning point that transforms a beleaguered GLP‑1 leader into a viable ...

Amazon Pharmacy said on Friday it now offers Novo Nordisk's Wegovy weight-loss pill through insurance plans as well as ...

In the last week of December, while most of the U.S. was still in holiday mode, Novo Nordisk’s plant in North Carolina was ...

If you are wondering whether Novo Nordisk shares still offer value or if you might be arriving late, this article focuses ...

TUESDAY, Jan. 6, 2026 (HealthDay News) — A daily pill for weight loss has officially arrived in the U.S. On Monday, Novo ...

Novo Nordisk's Wegovy pill is now available, providing those seeking help with their weight a GLP-1 medicine in a pill for ...

Wegovy’s oral version of its injectable weight-loss drug is seeing tremendous interest, Novo Nordisk executive Dave Moore ...

Novo took its message to the people by setting up an exhibit at New York’s Grand Central Terminal. In a major thoroughfare at ...

Real-world data analysis suggests that families with at least one member using Novo Nordisk's GLP‑1 RA for weight management tend to reduce spending on alcohol and cigarettes. JAKARTA, Indonesia, Jan.